Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferasirox added to standard antiviral therapy in treatment-naive chronic hepatitis C
2009-012344-17Phase 2Active
- Sponsor
- AOU Policlinico di Modena
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of deferasirox in hepatitis C virus infection (3 arms), sponsored by AOU Policlinico di Modena. Primary endpoint: Primary safety, tolerability, and antiviral effect endpoint. Started Sep 2009; status: active.
02
Drugs
deferasirox
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2009-012344-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012344-17.